Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer

British Journal of Cancer

Volumn 76, Issue 10, 1997, Pages 1288-1292

  Scott, K A ^a   Walker, R A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Breast cancer; Cyclin E; Immunohistochemistry; Normal breast

Indexed keywords

CYCLIN E;

ARTICLE; BREAST; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CANCER INVASION; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; DIFFERENTIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0030667313     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.550     Document Type: Article

References (25)

1. Alpers CE and Wellings SR (1985) The prevalence of carcinoma in situ in normal and cancer associated breasts. Human Pathol 16: 746-807
2. Cattoretti G, Becker MHG, Key G. Duchroi M, Schulter C. Galle J and Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki67 antigen deled proliferating cells in microwave-processed formalin fixed paraffin sections. J Pathol 168: 357-363
3. Dulic V, Lees E and Reed S (1992) Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958-1961
4. Dupont WD and Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Eng J Med 312: 146- 451
5. Dutta A, Chandra R, Leiter LM and Lester S (1995) Cyclins as markers of tumour proliferation: immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 92: 5386-5390
6. Elston CW and Ellis IO (1991) Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology 19: 403-410
7. Gillet C, Smith P, Gregory W, Richards M, Millis R, Peters G and Barnes D (1996) Cyclin D1 and prognosis in human breast cancer, Int J Cancer 69: 92-99
8. Gretarsdottir S, Tryggvadottir L. Jonasson JG, Sigurdsson H. Olafsdottir K, Agnarsson BA, Ogmundsdottir H and Eyfjord JE (1996) TP53 mutations analysis on breast carcinomas: a study of paraffin-cmbedded archival material. Br J Cancer 74: 555-561
9. Hunter T and Pines J (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573-582
10. Isola J, Visakorpi T, Holli K and Kallioniemi OP (1992) Association of overexpression of tumour supressor protein p53 with rapid cell proliferation and poor prognosis in node negative breast cancer patients. J Natl Cancer Inst 84: 1109- 1114
11. Keyomarsi K and Pardee AB (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci 90: 1112-1116
12. Keyomarsi K, O'Leary N, Molnar G, Lees E. Fingert HJ and Paredde AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Ees 54: 380-385
13. Keyomarsi K, Conte D, Toyofuku W and Fox MP (1995) Deregulation of cyclin E in breast cancer. Oncogene 11: 941-950
14. Koff A, Giordano D, Desai K, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR and Roberts JM (1992) Formation and activation of a cyclin E/cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1694
15. Lagios MD (1990) Duct carcinoma in situ. Surg Clin N Amer 70: 853-871
16. La Thangue NB (1994) DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle conlrol. Trends Biochem Sci 19: 108-114
17. Murray AW and Hunt T (1993) Introduction to the cell cycle. In The cell cycle: An introduction, p. 1. Freeman: New York.
18. Nielsen NH, Arnerlov C, Emdin SO and Landberg G (1996) Cyelin H overexpression. a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 74: 874-880
19. Nevins JR (1992) E2F: a link between the Rb tumor supressor protein and viral oncoproteins. Science 258: 424-429
20. Norton AJ, Jordan S and Yeomans P (1994) Brief, high temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173: 371-379
21. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M (1995) Human cyclin E, a nuclear protein essential for the G 1 to S phase transition. Mol Cell Biol 15: 2612-2624
22. Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G (1993) Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 121: 101-111
23. Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246: 603-608
24. Rajakariar R and Walker RA (1995) Pathological and biological features of mammagraphically detected invasive breast carcinomas Br J Cancer 71: 150-154
25. Tsai L, Lees L, Faha B, Harlow E and Riabowol K (1993) The Cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8: 1593-1602